Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pistacia mutica extract refers to extracts derived from the fruit, leaves, or oil of *Pistacia atlantica* subsp. *mutica*, a subspecies of wild pistachio native to parts of the Middle East and Central Asia. Traditionally used in folk medicine for gastrointestinal disorders (such as peptic ulcer), wound healing, and as a mouth freshener, this botanical preparation is rich in bioactive compounds including monoterpenes (notably α-pinene), phenolic acids (gallic acid), flavonoids (quercetin derivatives), and triterpenes. Pharmacological studies have demonstrated antioxidant activity—enhancing enzymatic antioxidants like superoxide dismutase and catalase—antimicrobial effects, anti-inflammatory properties, antihyperlipidemic action, antidiabetic potential, and inhibition of melanogenesis via tyrosinase inhibition in cell models[1][2][3][7]. The mechanism is primarily attributed to its polyphenol content acting as free radical scavengers and enzyme modulators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pistacia mutica extract.